Safety and immunogenicity of conjugate quadrivalent meningococcal vaccination after hematopoietic cell transplantation

Immunization with the conjugated quadrivalent (serogroups A, C, Y, and W-135) meningococcal vaccine (MCV4) after hematopoietic cell transplantation (HCT) is recommended. However, immune responses to MCV4 have not been prospectively studied after HCT. We conducted a vaccine response study among 67 ad...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Cheng, Matthew P., Pandit, Alisha, Antin, Joseph H., Walsh, Stephen R., Huynh, Daisy, Ghobrial, Irene M., Baden, Lindsey R., Marty, Francisco M., Issa, Nicolas C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2018
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5998919/
https://ncbi.nlm.nih.gov/pubmed/29871892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018018911
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados